Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey P Jones

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Enzyme kinetics, inhibition, and regioselectivity of aldehyde oxidaseJohn T Barr, Kanika Choughule, Jeffrey P Jones
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2013
A guide to tracking single transmembrane proteins in supported lipid bilayersKumud Raj Poudel, Jeffrey P Jones, James A Brozik
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 7, 2013
Evaluation of rhesus monkey and guinea pig hepatic cytosol fractions as models for human aldehyde oxidaseKanika V Choughule, John T Barr, Jeffrey P Jones
Journal of the American Chemical Society|August 15, 2002
Evidence for two different active oxygen species in cytochrome P450 BM3 mediated sulfoxidation and N-dealkylation reactionsTrent J Volz, Denise A Rock, Jeffrey P Jones
Journal of Medicinal Chemistry|November 18, 2011
Comparative study of the affinity and metabolism of type I and type II binding quinoline carboxamide analogues by cytochrome P450 3A4Upendra P Dahal, Carolyn Joswig-Jones, Jeffrey P Jones
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 6, 2020
Site-Directed Mutagenesis at the Molybdenum Pterin Cofactor Site of the Human Aldehyde Oxidase: Interrogating the Kinetic Differences Between Human and Cynomolgus MonkeyArmina Abbasi, Carolyn A Joswig-Jones, Jeffrey P Jones
Biochemistry|June 2, 2004
Quantitative binding models for CYP2C9 based on benzbromarone analoguesCharles W Locuson, Denise A Rock, Jeffrey P Jones
Biochemical Pharmacology|June 3, 2015
Interspecies differences in the metabolism of methotrexate: An insight into the active site differences between human and rabbit aldehyde oxidaseKanika V Choughule, Carolyn A Joswig-Jones, Jeffrey P Jones
Journal of Medicinal Chemistry|December 24, 2004
Charge and substituent effects on affinity and metabolism of benzbromarone-based CYP2C19 inhibitorsCharles W Locuson, Hisashi Suzuki, Allan E Rettie, et al.
Molecular Pharmaceutics|June 24, 2016
Mechanism-Based Inhibition of CYP3A4 by Podophyllotoxin: Aging of an Intermediate Is Important for in Vitro/in Vivo CorrelationsCarlo Barnaba, Jaydeep Yadav, Swati Nagar, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Enzyme kinetics, inhibition, and regioselectivity of aldehyde oxidaseJohn T Barr, Kanika Choughule, Jeffrey P Jones
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2013
A guide to tracking single transmembrane proteins in supported lipid bilayersKumud Raj Poudel, Jeffrey P Jones, James A Brozik
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 7, 2013
Evaluation of rhesus monkey and guinea pig hepatic cytosol fractions as models for human aldehyde oxidaseKanika V Choughule, John T Barr, Jeffrey P Jones
Journal of the American Chemical Society|August 15, 2002
Evidence for two different active oxygen species in cytochrome P450 BM3 mediated sulfoxidation and N-dealkylation reactionsTrent J Volz, Denise A Rock, Jeffrey P Jones
Journal of Medicinal Chemistry|November 18, 2011
Comparative study of the affinity and metabolism of type I and type II binding quinoline carboxamide analogues by cytochrome P450 3A4Upendra P Dahal, Carolyn Joswig-Jones, Jeffrey P Jones
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 6, 2020
Site-Directed Mutagenesis at the Molybdenum Pterin Cofactor Site of the Human Aldehyde Oxidase: Interrogating the Kinetic Differences Between Human and Cynomolgus MonkeyArmina Abbasi, Carolyn A Joswig-Jones, Jeffrey P Jones
Biochemistry|June 2, 2004
Quantitative binding models for CYP2C9 based on benzbromarone analoguesCharles W Locuson, Denise A Rock, Jeffrey P Jones
Biochemical Pharmacology|June 3, 2015
Interspecies differences in the metabolism of methotrexate: An insight into the active site differences between human and rabbit aldehyde oxidaseKanika V Choughule, Carolyn A Joswig-Jones, Jeffrey P Jones
Journal of Medicinal Chemistry|December 24, 2004
Charge and substituent effects on affinity and metabolism of benzbromarone-based CYP2C19 inhibitorsCharles W Locuson, Hisashi Suzuki, Allan E Rettie, et al.
Molecular Pharmaceutics|June 24, 2016
Mechanism-Based Inhibition of CYP3A4 by Podophyllotoxin: Aging of an Intermediate Is Important for in Vitro/in Vivo CorrelationsCarlo Barnaba, Jaydeep Yadav, Swati Nagar, et al.
Pageof 7